Connor, Clark & Lunn Investment Management Ltd.
Position in LLY — ELI LILLY & Co
CIK 1596800
VANCOUVER, A1
Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$207,971,583
-$28,347,682 QoQ
Shares Held
173,392
-32.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#260
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $830,990,729 across 11 Drug Manufacturers - General names. LLY ranks #1 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
173,392 | $207,971,583 | |
| 2 | ABBV |
AbbVie Inc.
|
751,485 | $189,103,685 | |
| 3 | GSK |
GSK plc
|
2,767,591 | $145,077,119 | |
| 4 | NVS |
Novartis AG
|
740,532 | $116,056,174 | |
| 5 | SNY |
Sanofi
|
1,835,859 | $78,317,744 | |
| 6 | JNJ |
Johnson & Johnson
|
307,423 | $78,076,219 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
46,429 | $5,865,839 | |
| 8 | MRK |
Merck & Co., Inc.
|
38,087 | $4,894,179 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,971,583 | 173,392 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $236,319,265 | 256,933 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $82,643,974 | 76,901 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $37,440,410 | 49,070 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $32,797,165 | 42,073 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $28,095,806 | 34,018 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $22,642,760 | 29,330 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $51,423,501 | 58,044 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $49,252,672 | 54,400 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $38,572,034 | 49,581 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $37,939,348 | 65,085 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $59,468,347 | 110,715 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,890,857 | 12,561 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $13,477,861 | 39,246 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $23,011,336 | 62,900 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $23,698,644 | 73,291 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $61,963,595 | 191,110 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $59,296,917 | 207,064 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $31,991,800 | 115,820 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $36,309,045 | 157,148 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $42,501,595 | 185,176 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $44,730,312 | 239,430 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $14,219,535 | 84,219 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $27,122,740 | 183,237 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $13,977,792 | 85,137 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||